AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 27565270
Drug: ICS +
RxNorm normalized name: Culturelle Probiotics + Multivitamin Gummies (Mixed Berry)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ICS + LTRA treatment
Trial: 25335330
Drug: Yishen Jiejing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yishen Jiejing Decoction (YJD), 50 mL, twice a day for one month
Trial: 23050578
Drug: Nurse-led empowerment-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nurse-led empowerment-based intervention (eight weekly sessions including lifestyle modification education, empowerment group discussions, and exercise training)
Trial: 11094863
Drug: High-protein, very
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-protein, very low-calorie diet (VLCD; protein intake 1.5 to 2.0 g/kg of ideal body weight per day; 800 kcal/d) with weekly 2-hour clinic sessions including nutrition instruction, moderate-intensity exercise, and behavior-modification techniques.
Trial: 3086721
Drug: 125 mg
RxNorm normalized name: niacin 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 125 mg of penicillin V potassium twice daily
Trial: 31441895
Drug: Juglandis semen
RxNorm normalized name: Hippocastani semen
DrugBank: Horse chestnut (DB13195)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Juglandis semen complex extract (JCE) 1000 mg
Trial: 31441895
Drug: Juglandis semen
RxNorm normalized name: Hippocastani semen
DrugBank: Horse chestnut (DB13195)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Juglandis semen complex extract (JCE) 2000 mg
Trial: 25684164
Drug: Antiplatelet treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiplatelet treatment (126 participants)
Trial: 25684164
Drug: Anticoagulant treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anticoagulant treatment (124 participants)
Trial: 25684164
Drug: Antiplatelet treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiplatelet treatment (101 participants, per-protocol analysis)
Trial: 25684164
Drug: Anticoagulant treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anticoagulant treatment (96 participants, per-protocol analysis)
Trial: 22387567
Drug: Cinacalcet plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cinacalcet plus low-dose vitamin D
Trial: 10193284
Drug: Postoperative administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative administration of analgesia
Trial: 16470086
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg oral magnesium oxide daily
Trial: 15009817
Drug: Low-dose clonidine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose clonidine (25 micro g)
Trial: 15009817
Drug: Medium-dose clonidine
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medium-dose clonidine (150 micro g)
Trial: 10968501
Drug: Salbutamol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salbutamol (100 microg x puff(‐1)) via metered-dose inhaler (MDI) under pressure control (decelerating flow pattern)
Trial: 9247980
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of 35% CO2 gas mixture
Trial: 9247980
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of compressed air (control)
Trial: 7878168
Drug: Diazepam (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (0.1 mg/kg body weight i.v.)
Trial: 2094946
Drug: Controlled-release salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Controlled-release salbutamol (Group B)
Trial: 367406
Drug: Phenytoin treatment
RxNorm normalized name: Phenytoin
DrugBank: Phenytoin (DB00252)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Phenytoin treatment (aimed at maintaining plasma phenytoin levels between 40 and 80 mumol/litre)
Trial: 367406
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no phenytoin treatment)
Trial: 22564709
Drug: Lixisenatide (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lixisenatide (20 µg once daily)
Trial: 15588905
Drug: Transdermal iontophoretic
RxNorm normalized name: SYSTEM, TRANSDERMAL IONTOPHORETIC PCA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal iontophoretic delivery of R‐apomorphine with surfactant formulation pretreatment
Trial: 15588905
Drug: Transdermal iontophoretic
RxNorm normalized name: SYSTEM, TRANSDERMAL IONTOPHORETIC PCA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal iontophoretic delivery of R‐apomorphine without surfactant formulation (control)
Trial: 12122510
Drug: Intravenous liposomal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous liposomal amphotericin B + oral itraconazole
Trial: 8537671
Drug: 7‐valent pneumococcal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7‐valent pneumococcal conjugate vaccine (7‐OMPC) followed by one dose of 23‐valent polysaccharide pneumococcal vaccine (23‐PS)
Trial: 8537671
Drug: 23‐valent polysaccharide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 23‐valent polysaccharide pneumococcal vaccine (23‐PS) only
Trial: 1864539
Drug: Oral eudragit
RxNorm normalized name: EUDRAGIT RS 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral eudragit S coated 5 amino salicylic acid (n = 12)
Trial: 1864539
Drug: Rectal prednisolone
RxNorm normalized name: prednisolone Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal prednisolone enemas (n = 15)
Trial: 6357175
Drug: Cotrimoxazole injection
RxNorm normalized name: Clotrimazole
DrugBank: Clotrimazole (DB00257)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cotrimoxazole injection and placebo suppository
Trial: 6357175
Drug: Metronidazole suppository
RxNorm normalized name: metronidazole Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole suppository and cotrimoxazole injection
Trial: 6357175
Drug: Metronidazole suppository
RxNorm normalized name: metronidazole Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole suppository and placebo injection
Trial: 6357175
Drug: Placebo suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo suppository and placebo injection
Trial: 23222095
Drug: Buprenorphine taper
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine taper (7 vs 28 days)
Trial: 21272849
Drug: Prostaglandin E(2)
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prostaglandin E(2) controlled-release vaginal insert
Trial: 19304880
Drug: Granisetron transdermal
RxNorm normalized name: Granisetron Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granisetron transdermal patch (52 cm²)
Trial: 19304880
Drug: Oral granisetron
RxNorm normalized name: Granisetron
DrugBank: Granisetron (DB00889)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral granisetron (2 mg)
Trial: 16730534
Drug: Intratympanic steroid
RxNorm normalized name: ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intratympanic steroid treatment (0.5 mL of methylprednisolone acetate, 80 mg/2 mL, administered 4 times over 15 days)
Trial: 16730534
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no intratympanic treatment)
Trial: 12577354
Drug: Composite indigo
RxNorm normalized name: indigo
DrugBank: Indigo (DB16862)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Composite indigo capsule (control)
Trial: 29869538
Drug: Topical Coqun
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical Coqun (100 mg CQ10, 500 mg Vitamin E TPGS) twice daily for 1 month preoperatively
Trial: 29869538
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (pseudo-exfoliative glaucoma group)
Trial: 29971527
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg dapagliflozin (n=21)
Trial: 29971527
Drug: 4 g
RxNorm normalized name: CTX4 Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 g OM‐3CA (n=20)
Trial: 29971527
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of dapagliflozin and OM‐3CA (n=22)
Trial: 22433020
Drug: Clarithromycin (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clarithromycin (15 mg/kg for 3 weeks)
Trial: 22433020
Drug: Control (regular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (regular GINA-guided exacerbation treatment)
Trial: 18506618
Drug: Assertive Community
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Assertive Community Treatment Only (ACTO)
Trial: 18506618
Drug: Treatment by
RxNorm normalized name: By Ache
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment by time interactions
Trial: 12963672
Drug: Family-focused therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Family-focused therapy (FFT) with pharmacotherapy
Trial: 12963672
Drug: Crisis management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crisis management (CM) with pharmacotherapy
Trial: 8695248
Drug: Ondansetron (OND)
RxNorm normalized name: Ondansetron
DrugBank: Ondansetron (DB00904)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ondansetron (OND) 8 mg x 3 i.v. on day 1 and 8 mg x 2 orally on day 2
Trial: 8695248
Drug: Granisetron (GRA)
RxNorm normalized name: Granisetron
DrugBank: Granisetron (DB00889)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Granisetron (GRA) 3 mg i.v. on day 1
Trial: 1809589
Drug: Augmented betamethasone
RxNorm normalized name: Augmented betamethasone dipropionate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Augmented betamethasone dipropionate (ABD) ointment 0.05% applied in an intermittent pulse dose regimen (three consecutive applications 12 h apart, once a week for a maximum treatment period of 6 months)
Trial: 3891159
Drug: Induction of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction of a hypnotic state
Trial: 30464392
Drug: Fimasartan/Rosuvastatin fixed-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fimasartan/Rosuvastatin fixed-dose combination (120 mg fimasartan and 20 mg rosuvastatin)
Trial: 30464392
Drug: Separate co-administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Separate co-administration of fimasartan and rosuvastatin
Trial: 22264499
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g XOS
Trial: 22264499
Drug: INU‐XOS (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: INU‐XOS (3 g inulin + 1 g XOS)
Trial: 21457067
Drug: Matsuda insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Matsuda insulin sensitivity index (MISI)
Trial: 18095238
Drug: Rosiglitazone (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosiglitazone (4 mg/day) + Metformin (2 g/day)
Trial: 18095238
Drug: Sulphonylurea (Glibenclamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulphonylurea (Glibenclamide 5 mg/day or Gliclazide 80 mg/day) + Metformin (2 g/day)
Trial: 8832493
Drug: MDI A
RxNorm normalized name: MDI-P
DrugBank: 3,4-Methylenedioxy-N-isopropylamphetamine (DB06112)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDI A (HFA-134a inhalation aerosol system), 4 inhalations four times per day for 14 days
Trial: 8832493
Drug: MDI A
RxNorm normalized name: MDI-P
DrugBank: 3,4-Methylenedioxy-N-isopropylamphetamine (DB06112)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDI A (HFA-134a inhalation aerosol system), 8 inhalations four times per day for 14 days
Trial: 8832493
Drug: MDI A
RxNorm normalized name: MDI-P
DrugBank: 3,4-Methylenedioxy-N-isopropylamphetamine (DB06112)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDI A (HFA-134a inhalation aerosol system)
Trial: 31048645
Drug: Postoperative intravenous
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative intravenous antibiotics once on the day of surgery and oral antibiotics for 4 days (Control group)
Trial: 31048645
Drug: No postoperative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No postoperative antibiotics (Experimental group)
Trial: 29507938
Drug: Daily antituberculosis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily antituberculosis therapy
Trial: 29507938
Drug: Part-daily antituberculosis
RxNorm normalized name: TRICARE PRENATAL 2-PART DAILY PRENATAL VITAMIN SYSTEM KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Part-daily antituberculosis therapy
Trial: 29507938
Drug: Intermittent antituberculosis
RxNorm normalized name: Mycobacterium tuberculosis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent antituberculosis therapy
Trial: 27764725
Drug: H-BE (600-mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H-BE (600-mg total anthocyanins)
Trial: 11878655
Drug: Rectal paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal paracetamol (40-60 mg kg-1 single dose)
Trial: 11878655
Drug: Rectal paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal paracetamol (14-20 mg kg-1 repeat dosing)
Trial: 11878655
Drug: Rectal paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal paracetamol (10-20 mg kg-1 single dose)
Trial: 10342698
Drug: Improved sexually-transmitted
RxNorm normalized name: Improvest
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Improved sexually-transmitted disease (STD) treatment services
Trial: 7774469
Drug: PEG‐ELS +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PEG‐ELS + oral metoclopramide (n = 99)
Trial: 7774469
Drug: Oral sodium
RxNorm normalized name: Oral Film
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral sodium phosphate (n = 106)
Trial: 2330929
Drug: Cold-recombinant bivalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cold-recombinant bivalent A vaccine
Trial: 2330929
Drug: Trivalent inactivated
RxNorm normalized name: diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated Injection [Tdvax]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trivalent inactivated vaccine
Trial: 31838622
Drug: Magnesium and
RxNorm normalized name: Calcium, Magnesium and Zinc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium and Ketamine (Mg + K)
Trial: 26652098
Drug: Chlorhexidine solution
RxNorm normalized name: CHLORHEXIDINE GLUCONATE 99.0 g in 1 L TOPICAL SOLUTION [CHLORHEXIDINE Solution]
DrugBank: Chlorhexidine (DB00878)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorhexidine solution and swab
Trial: 24299607
Drug: Xinfeng Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xinfeng Capsule
Trial: 24299607
Drug: Placebo (imitation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (imitation Xinfeng Capsule)
Trial: 19165109
Drug: SilvaSorb Gel
RxNorm normalized name: SILVASORB GEL,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SilvaSorb Gel
Trial: 19165109
Drug: Silvadene silver
RxNorm normalized name: silver sulfadiazine Topical Cream [Silvadene]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silvadene silver sulfadiazine cream
Trial: 9337167
Drug: Preincisional or
RxNorm normalized name: Medicated Pad or Tape
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preincisional or intraincisional infiltration with metronidazole (0.915 g metronidazole disodium phosphate injection in 100 mL 0.9% normal saline, injected 60-80 mL into subcutaneous tissue and muscle).
Trial: 9337167
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group received intravenous injection of metronidazole disodium phosphate and cephazolin postoperatively.
Trial: 8441838
Drug: Dopamine IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopamine IV at 2 micrograms/kg/min in 0.45% NaCl at 100 mL/h for 2 h during and after cardiac catheterization
Trial: 8441838
Drug: 0.45% NaCl
RxNorm normalized name: LVP solution Dextrose 5% with 0.45% NaCl intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.45% NaCl IV at 100 mL/h (Group 1)
Trial: 8441838
Drug: Dopamine IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopamine IV at 2 micrograms/kg/min in 0.45% NaCl at 100 mL/h (Group 2)
Trial: 3154147
Drug: 16-week treatment
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 16-week treatment program for wife assault
Trial: 30134136
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid (1 g administered intravenously)
Trial: 23796946
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (2.2 g/day LC-n3-FA)
Trial: 15001305
Drug: Home IV
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Home IV therapy
Trial: 15001305
Drug: Hospital IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hospital IV therapy
Trial: 9329413
Drug: Prednisone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone (1 mg/kg per day orally) for 5 days
Trial: 9329413
Drug: Bronchodilator reversibility
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bronchodilator reversibility testing with albuterol
Trial: 29362512
Drug: Aripiprazole (APZ)
RxNorm normalized name: Aripiprazole
DrugBank: Aripiprazole (DB01238)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Aripiprazole (APZ) titrated to 15 mg
Trial: 9013228
Drug: Chlormadinone acetate
RxNorm normalized name: Chlormadinone acetate
DrugBank: Chlormadinone acetate (DB15903)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlormadinone acetate (100 mg/day)
Trial: 4008128
Drug: Low-dose marijuana
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose marijuana cigarettes
Trial: 4008128
Drug: High-dose marijuana
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose marijuana cigarettes
Trial: 27028911
Drug: Doxycycline (12-week
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline (12-week oral course)
Trial: 27028911
Drug: Clarithromycin plus
RxNorm normalized name: Clarithromycin
DrugBank: Clarithromycin (DB01211)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clarithromycin plus hydroxychloroquine (12-week oral course)
Trial: 24295850
Drug: 10 day
RxNorm normalized name: DexPak 10 Day Taperpak
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 day sequential therapy (SEQ)
Trial: 24295850
Drug: 10 day
RxNorm normalized name: DexPak 10 Day Taperpak
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 day modified bismuth quadruple therapy (QUAD)
Trial: 11450675
Drug: Single 200-mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single 200-mg dose of doxycycline
Trial: 9549926
Drug: Antithrombotic drugs
RxNorm normalized name: Heparin group antithrombotic drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antithrombotic drugs (e.g., aspirin)
Trial: 2903170
Drug: Sodium valproate
RxNorm normalized name: sodium valproate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium valproate (1600 mg/day) for 6 days
Trial: 16971821
Drug: 12-week outpatient
RxNorm normalized name: risedronate
DrugBank: Risedronic acid (DB00884)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 12-week outpatient treatment
Trial: 14594917
Drug: Cognitive-behavioural treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioural treatment (CBT) programme
Trial: 10511327
Drug: Antioxidant supplementation
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant supplementation (24 mg of beta-carotene, 1000 mg of ascorbate, and 800 IU of alpha-tocopherol daily for 12 weeks)
Trial: 10511327
Drug: Placebo (baseline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (baseline and post-treatment phases)
Trial: 7865226
Drug: Doxycycline (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline (100 mg and 600 mg)
Trial: 7865226
Drug: Corynebacterium parvum
RxNorm normalized name: Corynebacterium parvum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corynebacterium parvum (1 mg and 7 mg)
Trial: 7286357
Drug: Clofazimine 100
RxNorm normalized name: clofazimine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clofazimine 100 mg daily with sun exposure
Trial: 7286357
Drug: Clofazimine 100
RxNorm normalized name: clofazimine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clofazimine 100 mg daily without sun exposure
Trial: 27292774
Drug: Amoxicillin (AMX)
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin (AMX) at 10 mg/kg body weight (b.w.)
Trial: 27292774
Drug: Amoxicillin (AMX)
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin (AMX) at 20 mg/kg body weight (b.w.)
Trial: 19608812
Drug: Fosaprepitant 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fosaprepitant 200 mg IV
Trial: 19608812
Drug: Moxifloxacin 400
RxNorm normalized name: moxifloxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxifloxacin 400 mg per os
Trial: 17512226
Drug: PTFE patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PTFE patch insertion